Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    INSIDE INDUSTRY

      Drug development companies in APAC need to raise their game to capitalise on the $33bn+ immuno-oncology treatment opportunity

      Singapore’s pharmaceutical market value to reach $1.15 billion by 2021

      Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients

      FDA approves Amgen’s Repatha (evolocumab) to prevent heart attack and stroke

      FDA approves first drug for rare disease, eosinophilic granulomatosis with polyangiitis

      FDA approves first biosimilar for the treatment of certain breast and stomach cancers

      FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

      Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer

      Globavir announces partnership with Singhealth Duke-NUS Academic Medical Centre to study dengue treatment

      Mundipharma secures exclusive license for the development and commercialisation of PAION’s remimazolam in Japan